These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 30747085

  • 1. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S, Sobh R.
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [Abstract] [Full Text] [Related]

  • 2. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV, Lahiri A, Lim E, Hopkins D, Corder R.
    J Am Coll Cardiol; 2006 May 02; 47(9):1850-7. PubMed ID: 16682312
    [Abstract] [Full Text] [Related]

  • 3. Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients.
    Mikami S, Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Matsuhisa M, Ito T, Imai E, Hori M.
    Hypertens Res; 2008 Jun 02; 31(6):1163-70. PubMed ID: 18716364
    [Abstract] [Full Text] [Related]

  • 4. Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes.
    Maser RE, Lenhard MJ, Sneider MB, Pohlig RT.
    Endocr Pract; 2015 Jan 02; 21(1):14-22. PubMed ID: 25100392
    [Abstract] [Full Text] [Related]

  • 5. Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients.
    Kurnatowska I, Grzelak P, Kaczmarska M, Stefańczyk L, Nowicki M.
    Nephron Clin Pract; 2011 Jan 02; 117(4):c297-304. PubMed ID: 20861651
    [Abstract] [Full Text] [Related]

  • 6. Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients.
    Ishiyama M, Suzuki E, Katsuda J, Murase H, Tajima Y, Horikawa Y, Goto S, Fujita T, Takeda J.
    Diabetes Res Clin Pract; 2009 Aug 02; 85(2):189-96. PubMed ID: 19497632
    [Abstract] [Full Text] [Related]

  • 7. The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM.
    Jung CH, Lee WY, Kim SY, Jung JH, Rhee EJ, Park CY, Mok JO, Oh KW, Kim CH, Park SW, Kim SW.
    Acta Diabetol; 2010 Dec 02; 47 Suppl 1():145-52. PubMed ID: 19787288
    [Abstract] [Full Text] [Related]

  • 8. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers.
    Anand DV, Lim E, Darko D, Bassett P, Hopkins D, Lipkin D, Corder R, Lahiri A.
    J Am Coll Cardiol; 2007 Dec 04; 50(23):2218-25. PubMed ID: 18061069
    [Abstract] [Full Text] [Related]

  • 9. [Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].
    Shiota J, Izumi N, Kasahara H, Tagawa H, Chiba T, Nihei H.
    Nihon Jinzo Gakkai Shi; 2010 Dec 04; 52(8):1022-8. PubMed ID: 21254698
    [Abstract] [Full Text] [Related]

  • 10. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.
    Tavintharan S, Pek LT, Liu JJ, Ng XW, Yeoh LY, Su Chi L, Chee Fang S.
    Diab Vasc Dis Res; 2014 Sep 04; 11(5):359-62. PubMed ID: 25005034
    [Abstract] [Full Text] [Related]

  • 11. Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification.
    Pérez de Ciriza C, Moreno M, Restituto P, Bastarrika G, Simón I, Colina I, Varo N.
    Clin Biochem; 2014 Dec 04; 47(18):272-8. PubMed ID: 25218813
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of plaque calcification regulators osteoprotegerin and matrix Gla-proteins in stable angina and acute myocardial infarction.
    Margonato A, Gorla R, Macchi A, Buzzetti F, Franzoni I, Pedrigi MC, Rosa I, Sirtori M, Villa I, Rubinacci A.
    J Cardiovasc Med (Hagerstown); 2015 Mar 04; 16(3):156-62. PubMed ID: 24566391
    [Abstract] [Full Text] [Related]

  • 14. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients.
    Morena M, Dupuy AM, Jaussent I, Vernhet H, Gahide G, Klouche K, Bargnoux AS, Delcourt C, Canaud B, Cristol JP.
    Nephrol Dial Transplant; 2009 Nov 04; 24(11):3389-97. PubMed ID: 19574342
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).
    Abedin M, Omland T, Ueland T, Khera A, Aukrust P, Murphy SA, Jain T, Gruntmanis U, McGuire DK, de Lemos JA.
    Am J Cardiol; 2007 Feb 15; 99(4):513-8. PubMed ID: 17293196
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?
    Hosbond SE, Diederichsen AC, Saaby L, Rasmussen LM, Lambrechtsen J, Munkholm H, Sand NP, Gerke O, Poulsen TS, Mickley H.
    Atherosclerosis; 2014 Oct 15; 236(2):230-6. PubMed ID: 25104079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.